What factors account for hormone replacement therapy prescribing frequency?

Area of Science:

• Menopause and hormone replacement therapy (HRT) research.
• Healthcare provider prescribing patterns.
• Women's health and preventive cardiology.

Background:

• Hormone replacement therapy (HRT) is a common treatment for menopausal symptoms.
• Provider characteristics and beliefs may influence HRT prescribing frequency.
• Understanding these factors is crucial for optimizing menopausal care.

Purpose of the Study:

• To investigate the relationship between hormone replacement therapy (HRT) prescribing frequency and provider characteristics.
• To examine how provider attitudes and beliefs about menopause and HRT impact prescribing habits.

Main Methods:

• A mailed survey was administered to 250 family practice physicians, 22 gynecologists, and 13 women's health specialists/nurse midwives.
• HRT prescribing frequency was calculated using pharmacy and visit data for women aged 50-80.
• Logistic regression analyzed the association between prescribing frequency and provider demographics, attitudes, and beliefs.

Main Results:

• Female providers were less likely to prescribe HRT compared to male providers (OR 0.38).
• Providers who believed HRT prevents heart disease were more likely to prescribe it (OR 2.66).
• Higher scores on an HRT encouragement scale correlated with increased HRT prescribing (OR 2.50).

Conclusions:

• Provider gender and positive attitudes towards HRT are significant predictors of prescribing frequency.
• These findings highlight the influence of provider beliefs on clinical practice in menopausal hormone therapy.